Cited 7 times in
Etanercept-induced clinical remission of type II pityriasis rubra pilaris with rheumatoid arthritis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김수찬 | - |
dc.contributor.author | 박민찬 | - |
dc.contributor.author | 김종훈 | - |
dc.date.accessioned | 2014-12-19T17:05:42Z | - |
dc.date.available | 2014-12-19T17:05:42Z | - |
dc.date.issued | 2012 | - |
dc.identifier.issn | 0385-2407 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/90766 | - |
dc.description.statementOfResponsibility | open | - |
dc.format | application/pdf | - |
dc.relation.isPartOf | JOURNAL OF DERMATOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Adolescent | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Antirheumatic Agents/therapeutic use* | - |
dc.subject.MESH | Arthritis, Rheumatoid/complications | - |
dc.subject.MESH | Arthritis, Rheumatoid/diagnosis | - |
dc.subject.MESH | Arthritis, Rheumatoid/drug therapy* | - |
dc.subject.MESH | Biopsy | - |
dc.subject.MESH | Etanercept | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Immunoglobulin G/therapeutic use* | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Pityriasis Rubra Pilaris/complications | - |
dc.subject.MESH | Pityriasis Rubra Pilaris/diagnosis | - |
dc.subject.MESH | Pityriasis Rubra Pilaris/drug therapy* | - |
dc.subject.MESH | Receptors, Tumor Necrosis Factor/therapeutic use* | - |
dc.subject.MESH | Remission Induction | - |
dc.subject.MESH | Skin/drug effects | - |
dc.subject.MESH | Skin/pathology | - |
dc.subject.MESH | Treatment Outcome | - |
dc.title | Etanercept-induced clinical remission of type II pityriasis rubra pilaris with rheumatoid arthritis | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Dermatology (피부과학) | - |
dc.contributor.googleauthor | Jong Hoon Kim | - |
dc.contributor.googleauthor | Min-Chan Park | - |
dc.contributor.googleauthor | Soo-Chan Kim | - |
dc.identifier.doi | 10.2340/00015555-1367 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A01470 | - |
dc.contributor.localId | A00637 | - |
dc.contributor.localId | A05233 | - |
dc.relation.journalcode | J01372 | - |
dc.identifier.eissn | 1346-8138 | - |
dc.identifier.pmid | 22513698 | - |
dc.subject.keyword | Adolescent | - |
dc.subject.keyword | Adult | - |
dc.subject.keyword | Antirheumatic Agents/therapeutic use* | - |
dc.subject.keyword | Arthritis, Rheumatoid/complications | - |
dc.subject.keyword | Arthritis, Rheumatoid/diagnosis | - |
dc.subject.keyword | Arthritis, Rheumatoid/drug therapy* | - |
dc.subject.keyword | Biopsy | - |
dc.subject.keyword | Etanercept | - |
dc.subject.keyword | Female | - |
dc.subject.keyword | Humans | - |
dc.subject.keyword | Immunoglobulin G/therapeutic use* | - |
dc.subject.keyword | Male | - |
dc.subject.keyword | Middle Aged | - |
dc.subject.keyword | Pityriasis Rubra Pilaris/complications | - |
dc.subject.keyword | Pityriasis Rubra Pilaris/diagnosis | - |
dc.subject.keyword | Pityriasis Rubra Pilaris/drug therapy* | - |
dc.subject.keyword | Receptors, Tumor Necrosis Factor/therapeutic use* | - |
dc.subject.keyword | Remission Induction | - |
dc.subject.keyword | Skin/drug effects | - |
dc.subject.keyword | Skin/pathology | - |
dc.subject.keyword | Treatment Outcome | - |
dc.contributor.alternativeName | Kim, Soo Chan | - |
dc.contributor.alternativeName | Park, Min Chan | - |
dc.contributor.affiliatedAuthor | Park, Min Chan | - |
dc.contributor.affiliatedAuthor | Kim, Soo Chan | - |
dc.contributor.affiliatedAuthor | Kim, Jong Hoon | - |
dc.citation.volume | 92 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 399 | - |
dc.citation.endPage | 400 | - |
dc.identifier.bibliographicCitation | JOURNAL OF DERMATOLOGY, Vol.92(4) : 399-400, 2012 | - |
dc.identifier.rimsid | 33522 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.